Your browser doesn't support javascript.
loading
Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.
Harjani, Jitendra R; Yap, Beow Keat; Leung, Eleanor W W; Lucke, Andrew; Nicholson, Sandra E; Scanlon, Martin J; Chalmers, David K; Thompson, Philip E; Norton, Raymond S; Baell, Jonathan B.
Afiliação
  • Harjani JR; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
  • Yap BK; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
  • Leung EW; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
  • Lucke A; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
  • Nicholson SE; The Walter and Eliza Hall Institute of Medical Research , Parkville, Victoria 3052, Australia.
  • Scanlon MJ; The Department of Medical Biology, University of Melbourne , Parkville, Victoria 3052, Australia.
  • Chalmers DK; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
  • Thompson PE; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
  • Norton RS; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
  • Baell JB; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Victoria 3052, Australia.
J Med Chem ; 59(12): 5799-809, 2016 06 23.
Article em En | MEDLINE | ID: mdl-27214043
SPRY domain-containing suppressor of cytokine signaling box protein (SPSB) 2-deficient macrophages have been found to exhibit prolonged expression of inducible nitric oxide synthase (iNOS) and enhanced killing of persistent pathogens, suggesting that inhibitors of the SPSB2-iNOS interaction have potential as novel anti-infectives. In this study, we describe the design, synthesis, and characterization of cyclic peptidomimetic inhibitors of the SPSB2-iNOS interaction constrained by organic linkers to improve stability and druggability. SPR, ITC, and (19)F NMR analyses revealed that the most potent cyclic peptidomimetic bound to the iNOS binding site of SPSB2 with low nanomolar affinity (KD 29 nM), a 10-fold improvement over that of the linear peptide DINNN (KD 318 nM), and showed strong inhibition of SPSB2-iNOS interaction in macrophage cell lysates. This study exemplifies a novel approach to cyclize a Type II ß-turn linear peptide and provides a foundation for future development of this group of inhibitors as new anti-infectives.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Desenho de Fármacos / Óxido Nítrico Sintase Tipo II / Proteínas Supressoras da Sinalização de Citocina / Peptidomiméticos / Domínio B30.2-SPRY Limite: Animals Idioma: En Revista: J Med Chem Assunto da revista: QUIMICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Desenho de Fármacos / Óxido Nítrico Sintase Tipo II / Proteínas Supressoras da Sinalização de Citocina / Peptidomiméticos / Domínio B30.2-SPRY Limite: Animals Idioma: En Revista: J Med Chem Assunto da revista: QUIMICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos